Left Menu
Development News Edition

Fujifilm partners Shanghai firm to seek China COVID-19 approval for Avigan

That followed results from a late-stage study in Japan that showed the antiviral drug reduced recovery time for patients with non-severe symptoms. Avigan, originally developed as an emergency flu drug and known generically worldwide as favipiravir, has been approved in India and Russia to treat COVID-19.

Reuters | Updated: 22-10-2020 09:21 IST | Created: 22-10-2020 09:21 IST
Fujifilm partners Shanghai firm to seek China COVID-19 approval for Avigan

Japan's Fujifilm Holdings Corp said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co to seek approval in China for Avigan to treat COVID-19 and influenza.

Carelink will use Fujifilm's data on Avigan's treatment of novel coronavirus infections and influenza to seek imported drug approval in China, Fujifilm said in a statement. The two companies also plan to develop an injectable form of the drug. Fujifilm said last week it was seeking approval for Avigan as a treatment for COVID-19 in Japan. That followed results from a late-stage study in Japan that showed the antiviral drug reduced recovery time for patients with non-severe symptoms.

Avigan, originally developed as an emergency flu drug and known generically worldwide as favipiravir, has been approved in India and Russia to treat COVID-19. Fujifilm sold global rights in July on Avigan to India's Dr Reddy's Laboratories and Dubai-based Global Response Aid. That deal excluded China, Japan and Russia.

Last month, Fujifilm said the late-stage study of 156 COVID-19 patients in Japan showed that symptoms of those treated with Avigan improved after 11.9 days, versus 14.7 days for a placebo group. Results of the study, conducted by subsidiary Fujifilm Toyama Chemical, were found to be statistically significant.


TRENDING

OPINION / BLOG / INTERVIEW

Turbulence surrounding tobacco control in Ghana

... ...

Smart healthcare: IoT redefining the way healthcare is delivered

As the world is embracing the new wave of digitalization triggered by the pandemic and the arrival of 5G, the adoption of IoT devices will further boom. With adoption set to soar, IoT security issues and other challenges cant be ignored any...

Refugee compassion and response: Ideas to mitigate disasters now and in their future

Their homeland becomes a forbidden territory for them and more likely than not, their journey to foreign soil is no less traumatizing, not to say deadly. It is crucial to help refugees live a life of dignity and purpose....

Inadequate water infrastructure causes a tidal wave of coronavirus in rural Alaska

... ...

Videos

Latest News

UP governor gives nod to ordinance against forcible religious conversions

Uttar Pradesh Governor Anandiben Patel on Saturday gave assent to an ordinance against forcible or fraudulent religious conversions that provides for imprisonment up to 10 years and a maximum fine of Rs 50,000 under different categories. Th...

60 day old tiger cub rescued, efforts on to nurse it back to health

A very weak 60 day old tiger cub has been rescued from near a temple on the Tamil Nadu-Kerala border and efforts are on to nurse it back to health as it could not even stand now, forest department officials said on Saturday. The cub was sus...

GST officers arrest one for Rs 129 cr tax evasion through illegal manufacture, supply of cigarettes

Officers of GST investigation arm DGGI have arrested a Haryana resident on charges of manufacturing and supplying cigarettes illegally and thereby evading taxes of over Rs 129 crore, the Finance Ministry has said. The Directorate General of...

Cricket-Sydney Thunder outshine Melbourne Stars to win Women's Big Bash League

The Sydney Thunder secured their second Womens Big Bash League WBBL title on Saturday after an emphatic seven-wicket victory over Melbourne Stars in the final in Sydney. Set a target of just 87 runs to win their first title since the inaugu...

Give Feedback